Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.0080 USD
Change Today 0.00 / 0.00%
Volume 0.0
AXMP On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 03/24/15 All times are local (Market data is delayed by at least 15 minutes).

axm pharma inc (AXMP) Snapshot

Open
$0.0080
Previous Close
$0.0080
Day High
$0.0080
Day Low
$0.0080
52 Week High
02/20/15 - $0.02
52 Week Low
09/5/14 - $0.0020
Market Cap
179.2K
Average Volume 10 Days
7.1K
EPS TTM
$-0.51
Shares Outstanding
22.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AXM PHARMA INC (AXMP)

Related News

No related news articles were found.

axm pharma inc (AXMP) Related Businessweek News

No Related Businessweek News Found

axm pharma inc (AXMP) Details

AXM Pharma, Inc. produces, markets, and distributes pharmaceutical products in China. The company provides Asarone, an anti-septic, anti-inflammatory, asthma reducing, and coughs prevention medicine for the treatment of infantile pneumonia, child pneumonia, adult bacterial pneumonia, and chronic and acute bronchitis; and Lifupeng for treatment of tuberculosis. It also offers Weifukang, an antiseptic cream for cleansing acne; and for relieving the symptoms of eczema, psoriasis, and other skin irritations, such as contact dermatitis. In addition, the company provides Whisper, a feminine hygiene product; Qiyao Diabetes Capsule, an herbal formulation used as an adjunctive therapy for Type II diabetes; children's vitamin and vitamin supplements; anti-depression and anti-fatigue compound; Soluleaves, an oral drug delivery technology; Elegance, a menstrual relief lotion; LiveComf, a compound sulfur cream used to alleviate dermatitis, seborrheica, scabies, acne, and eczema; Bodyward, a tablet to treat allergy caused by penicillin; Reheal, a capsule used to treat reduced memory capacity and impairment of cerebral function caused by acute/chronic cerebrovascular disease, cerebral trauma, and toxic cerebral disease; and LifeGate, an anti fatigue capsule used for enhancing energy and vitality. It owns 42 permitted and licensed formulas, which company has the right to manufacture and distribute in China. The company was founded in 1999 and is headquartered in Diamond Bar, California.

150 Employees
Last Reported Date: 01/16/09
Founded in 1999

axm pharma inc (AXMP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

axm pharma inc (AXMP) Key Developments

Axm Pharma Files Form 15

Axm Pharma, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common stock, $0.001 par value under the Securities Exchange Act of 1934, as amended.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AXMP:US $0.01 USD 0.00

AXMP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AXMP.
View Industry Companies
 

Industry Analysis

AXMP

Industry Average

Valuation AXMP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AXM PHARMA INC, please visit www.axmpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.